Literature DB >> 2011251

Anticardiolipin antibodies: a study of frequency in TIA and stroke.

D C Hess1, J Krauss, R J Adams, F T Nichols, D Zhang, H A Rountree.   

Abstract

We undertook a prospective study of consecutive patients to determine the frequency of elevated IgG and IgM anticardiolipin antibodies in transient ischemic attack and ischemic stroke and found elevated IgG antibodies in 8.2% (9 of 110) and IgM in 9.1% (10 of 110), only the former being significantly greater than in a healthy control population. We suggest that anticardiolipin screening be concentrated on the young.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2011251     DOI： 10.1212/wnl.41.4.525

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  4 in total

Review 1.  Antiphospholipid antibodies and stroke.

Authors:  Stanley Tuhrim
Journal:  Curr Cardiol Rep       Date:  2004-03       Impact factor: 2.931

2.  Cost-effective investigation of patients with suspected transient ischaemic attacks.

Authors:  G J Hankey; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 3.  Anticardiolipin antibodies and cardiovascular disease.

Authors:  K W Muir
Journal:  J R Soc Med       Date:  1995-08       Impact factor: 5.344

4.  Prevalence and significance of anticardiolipin antibodies in Crohn's disease.

Authors:  P Chamouard; L Grunebaum; M L Wiesel; J M Freyssinet; B Duclos; J P Cazenave; R Baumann
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.